Abstract
In this work we analyze the cumulative curves of deaths attributed to COVID-19 in the 26 Brazilian States and the Federal District up until August 21, 2020. Mathematical growth models implemented by the application ModInterv COVID-19, which can be accessed via internet browser or via a mobile app, were used to investigate at which stage the epidemic is in each of the Brazilian federal units. The analysis revealed that almost all states in the Northern and Northeastern regions were already in the saturation phase, meaning that the epidemic was relatively under control, whereas in all Southern states and in most states in the Midwest the epidemic was still accelerating or showed only a slight deceleration. The Southeastern region presented a great diversity of epidemic stages, with each state being found at a different stage, ranging from acceleration to saturation. It is argued that understanding this heterogeneous geographical distribution of the epidemic is relevant for public health authorities, as it may help in devising more effective strategies against the COVID-19 pandemic in a continental country like Brazil.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by the National Council for Scientific and Technological Development (CNPq) in Brazil, through the research grants Nos. 303772/2017-4 (GLV), 312612/2019-2 (AMSM), and 305305/2019-0 (RO), and a PhD Fellowship grant No. 167348/2018-3 (AAB).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Does not apply. The manuscript reports only theoretical and numerical studies based solely on publicly available data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Gerson C. Duarte-Filho, E-mail: gcdf{at}ufs.br
Arthur A. Brum, E-mail: arthurbrum{at}df.ufpe.br
Raydonal Ospina, E-mail: raydonal{at}de.ufpe.br
Francisco A. G. Almeida, E-mail: falmeida{at}ufs.br
Antônio M. S. Macêdo, E-mail: antonio.smacedo{at}ufpe.br
Data Availability
The data used in our analysis are publicly available from the website https://covid19br.wcota.me, which compiles and updates the data from the bulletins published by the Health Departments of the Brazilian States.
